Article Data

  • Views 1645
  • Dowloads 151

Case Reports

Open Access

Management of cervical dysplasia in patient with Müllerian anomaly: diagnostic and therapeutic challenges

  • R. Sparic1,2
  • J. Dotlic1,2,*,
  • J. Kovac2,3
  • I. Babovic1,2
  • S. Buzadzic1
  • L. Mirkovi1,2
  • L. Nejkovic4
  • J. Stamenkovic1,2

1Clinic for Obstetrics and Gynecology, Clinical Centre of Serbia, Belgrade, Serbia

2Faculty of Medicine, University of Belgrade, Belgrade, Serbia

3Center for Radiology and Magnetic Resonance Imaging, Clinical Centre of Serbia, Belgrade, Serbia

4Clinic for Gynecology and Obstetrics "Narodni Front", Belgrade, Serbia

DOI: 10.12892/ejgo3550.2017 Vol.38,Issue 3,June 2017 pp.469-472

Published: 10 June 2017

*Corresponding Author(s): J. Dotlic E-mail: drenadot@gmail.com

Abstract

Purpose: The study aim was to report diagnostic and therapeutic challenges in treatment of a patient with cervical dysplasia and congenital uterine anomaly. Case Report: A 53-year-old women with Mullerian anomaly – uterus duplex (bicorporal septate uterus) and Yshaped endocervical canal was referred due to repeated abnormal Pap smears. She underwent endocervical curettage of both canals and the endocervical septum biopsy which revealed presence of cervical intraepithelial neoplasia (CIN) III. Cervical conization was considered technically unfeasible because of abnormal cervical anatomy (lesions deep in the cervical canal on the cervical bifurcation where the cervical wall is the thickest). Classical open abdominal hysterectomy was performed. Patient had two almost equally-sized, symmetrical uterine bodies connected in the isthmico-cervical region, with normal left and obstructed right hemi-vagina. Postoperative histopathological findings confirmed that dysplasia was located in the region where two endocervical canals conjoined. Conclusion: Diagnostic and therapeutic approach to patients with uterine anomalies has to be individualized, based on anomaly type, patient's age, reproductive history, and patient's preferences.

Keywords

Uterus duplex; Cervical dysplasia; Conization; Hysterectomy; Diagnosis; Therapy.

Cite and Share

R. Sparic,J. Dotlic,J. Kovac,I. Babovic,S. Buzadzic,L. Mirkovi,L. Nejkovic,J. Stamenkovic. Management of cervical dysplasia in patient with Müllerian anomaly: diagnostic and therapeutic challenges. European Journal of Gynaecological Oncology. 2017. 38(3);469-472.

References

[1] Saravelos S.H., Cocksedge K.A., Li T.C.: “Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal”. Hum. Reprod. Update, 2008, 14, 415.

[2] Chan Y.Y., Jayaprakasan K., Zamora J., Thornton J.G., Raine-Fenning N., Coomarasamy A.: “The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review”. Hum. Reprod. Update, 2011, 17, 761.

[3] Kimball K.J., Rocconi R.P., Straughn J.M., Conner M.G., Alvarez R.D.: “Unilateral cervical cancer in a patient with cervix duplex”. Gynecol. Oncol., 2006, 103, 346.

[4] Martin-Hirsch P.P., Paraskevaidis E., Bryant A., Dickinson H.O.: “Surgery for cervical intraepithelial neoplasia”. Cochrane Database Syst. Rev., 2013, 12, CD001318.

[5] Oppelt P., von Have M., Paulsen M., Strissel P., Strick R., Brucker S., et al.: “Female genital malformations and their associated abnormalities”. Fertil. Steril., 2007, 87, 335.

[6] Caliskan E., Cakiroglu Y., Turkoz E., Corakci A.: “Leiomyoma on the septum of a septate uterus with double cervix and vaginal septum: a challenge to manage”. Fertil. Steril., 2008, 89, 456.e3

[7] Sugimori H., Hachisuga T., Nakamura S., Matsuo N., Nakamura G.: Cervical cancers in uterus didelphys”. Gynecol. Oncol., 1990, 36, 439.

[8] Beyer W.F., Freissler G., Schlotter C.M., Kuhn H.: “Uterus septus with adenocarcinoma of one half of the uterus”. Geburtshilfe Frauenheilkd., 1984, 44, 513.

[9] DelMistro A., Matteucci M., Insacco E.A., Onnis G.L., Da Re F., Baboci L., et al.: “Long-term clinical outcome after treatment for high-grade cervical lesions: a retrospective monoinstitutional cohort study”. Biomed. Res. Int., 2015, 2015, 984528.

[10] Kyrgiou M., Valasoulis G., Founta C., Koliopoulos G., Karakitsos P., Nasioutziki M., et al.: “Clinical management of HPV-related disease of the lower genital tract”. Ann. N. Y. Acad. Sci., 2010, 1205, 57.

[11] Kocken M., Helmerhorst T.J., Berkhof J., Louwers J.A., Nobbenhuis M.A., Bais A.G., et al.: “Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multicohort study”. Lancet Oncol., 2011, 12, 441.

[12] Milenkovic V., Sparic R., Dotlic J., Tulic L., Mirkovic L., Milenkovic S., Atanackovic J.: “Reliability and relationship of colposcopical, cytological and histopathological findings in the diagnostic process”. Vojnosanit. Pregl., 2012, 69, 869.

[13] Lee C.D., Churn M., Haddad N., Davies-Humphries J., Kingston R.K., Jones B.: “Bilateral radical radiotherapy in a patient with a uterus didelphys”. Br. J. Radiol., 2000, 73, 553.

[14] Bakri Y., Salema H., Sadib A.R., Mansourb M.: “Bilateral and synchronous cervical carcinoma in situ in a didelphic uterus”. Int. J. Gynecol. Obstet., 1992, 37, 289.

[15] Erian J., Lee C., Watkinson S., Alsheikh Ali A., Chaudhari L., Hill N.: “Laparoscopic subtotal hysterectomy in a case of uterine didelphys”. Arch. Gynecol. Obstet., 2012, 285, 139.

Abstracted / indexed in

Web of Science (WOS) (On Hold)

Journal Citation Reports/Science Edition

Google Scholar

JournalSeek

Submission Turnaround Time

Top